+ Filter
Loading...
Custom Services order now ship next day

CD86

Loading...

Anti-CD86 Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Predicted to enable receptor ligand activity. Involved in several processes, including positive regulation of immunoglobulin production; positive regulation of non-canonical NF-kappaB signal transduction; and toll-like receptor 3 signaling pathway. Acts upstream of or within several processes, including cellular response to lipopolysaccharide; positive regulation of T cell proliferation; and toll-like receptor signaling pathway. Located in external side of plasma membrane and intracellular membrane-bounded organelle. Is expressed in central nervous system; mandible; and retina. Used to study Guillain-Barre syndrome. Human ortholog(s) of this gene implicated in several diseases, including Henoch-Schoenlein purpura; autoimmune disease (multiple); chronic lymphocytic leukemia; chronic obstructive pulmonary disease; and systemic scleroderma.
Protein class

CD markers, FDA approved drug targets

Predicted location

Intracellular, Membrane (different isoforms)

Single cell type specificity

Cell type enhanced (monocytes, Macrophages, Langerhans cells, Hofbauer cells, Kupffer cells, Microglial cells)

Immune cell specificity

Group enriched (non-classical monocyte, classical monocyte, intermediate monocyte, myeloid DC, memory B-cell, naive B-cell)

Cell line specificity

Cell line enriched (HDLM-2)

Interaction

Homodimer. Interacts with MARCH8. Interacts (via cytoplasmic domain) with PHB1 and PHB2; the interactions increases after priming with CD40 (By similarity). (Microbial infection) Interacts with adenovirus subgroup b fiber protein.

Molecular function

Host cell receptor for virus entry, Receptor

More Types Infomation
Go to compare

Go to compare